Posts tagged “GSK”
"Both Sir Andrew and the board are mindful of the impact this issue has had on the reputation of the company," GSK's chairman says. "As a result, the bonuses awarded for 2013 were lower than they otherwise might have been."
Anoro may help GSK protect its respiratory business, which made up 42 percent of its total pharmaceutical sales last year. The company's top-selling product, Advair for smokers' cough and asthma, is facing increasing competition from a newly approved generic in Europe and cheaper options in the U.S.
Data generated from the work will be made public for other scientists to use, a move that the U.S. National Institutes of Health called groundbreaking. The targeted diseases are some of the most prevalent conditions among Americans, costing the nation billions of dollars in treatment and lost productivity.
The warning is stark: "The danger we face today is the possibility that fewer people will enter highly technical fields in the decades ahead, at a time when demand for individuals with these kinds of skills is on the rise." U.S. student achievement in STEM fields lags many industrialized countries, and North Carolina students lag many states. But pharma companies are stepping in to help bridge the gap. WRALTechWire examines the report from Battelle and its implications for North Carolina as well as the U.S.
RTI partners on epilepsy work; SAS ranked in report; lawyers use cloud tools; Kenan-Flagler dean recommended; Abbott gets new trial
In our Bulldog Blog's latest life sciences and technology update: RTI partners on epilepsy network; SAS makes ranking; lawyers use more cloud tools; Kenan-Flagler dean recommended; AbbVie gets new drug trial.
GlaxoSmithKline says sales in China, where the company faces a bribery probe, have improved since the third quarter when revenue plunged 61 percent from a year earlier. In other news, the CDC affirmed support for rotavirus vaccines that combat severe diarrhea in infants from GSK and Merck.
Good news, bad news for GlaxoSmithKline on Monday: A treatment for metastatic lung cancer receives "Breakthrough Therapy" designation from the FDA. However, GSK also says it has dropped development of a muscular dystrophy treatment.
Doctors prefer to learn about treatment options from their peers, and payments make sense given the time and energy required to understand and share information, according to companies that plan to keep remunerating physicians.
GSK envisions a day when tiny implantable devices take the place of pills or injections. The pharma giant is collaborating with universities and encouraging research in bioelectronics, the use of electricity in therapeutic applications.
GlaxoSmithKline and Theravance received FDA approval on Anoro Ellipta, a drug indicated for treating chronic obstructive pulmonary disease (COPD). Read more about the drug and GSK's launch plans.
Drug giant GlaxoSmithKline, which is mired in a bribery scandal in China, says it is ending payments to doctors for promoting their products. The company also is changing its sales force compensation plan to reflect one implemented for its U.S. sales people in 2011.
Global drug giant GlaxoSmithKline is expanding its presence in India and in the U.K. with investments totaling some $1.35 billion. The home-country growth comes in the wake of the U.K.'s recently overhauled patent system.
GSK recommended withdrawing the article, published in 2010, after concluding an investigation in June that found some data had been misrepresented, London-based Glaxo said in a statement Friday. Five of the named authors, including the head of its Chinese research and development, resigned or were fired following the probe.
The Triangle's two major cancer centers didn't make the list, but GSK lines up six other major global research institutions to collaborate on research into new ways to fight cancer using a mix of drugs. It's the "new wave" of research, a GSK spokesperson says.
U.K. Prime Minister David Cameron defended GlaxoSmithKline over bribery allegations in China, saying the British drugmaker is an important and strong business. Cameron has been joined by GSK CEO Andrew Witty on his trade mission to China this week.